Craig-Hallum analyst Jeff Van Rhee maintained a Buy rating on Cellebrite DI (CLBT – Research Report) today. The company’s shares closed yesterday at $8.48.
Van Rhee covers the Technology sector, focusing on stocks such as Asure, Cellebrite DI, and Ebix. According to TipRanks, Van Rhee has an average return of 10.8% and a 52.04% success rate on recommended stocks.
Currently, the analyst consensus on Cellebrite DI is a Moderate Buy with an average price target of $9.33.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $8.60 and a one-year low of $3.96. Currently, Cellebrite DI has an average volume of 557.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cellebrite DI (CLBT) Company Description:
Cellebrite offers digital intelligence solutions. Its platform and solutions help law enforcement agencies (police departments, armed services, public defenders, start departments) and enterprise customers to better collect, review, analyze, and manage digital data in legally sanctioned investigations.
Read More on CLBT:
